-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Ref: Schneider H,et al.Stroke2018 Jun;49 (6): 1511-1514doi: 10.1161/STROKEAHA.118.020679Epub 2018 May 2.)Brain Bleeding (ICH) score is a common scale for analyzing the prognosis of neurofunction in patients with acute ICH, and is commonly used to assess the prognosis of 1 month and 12 months after brain haemorrhageThe spectre shown by CT angiography (CTA) is a recently reported indicator of predicted rebleeding and functional prognosisIt is not known whether the combination of the two will improve the predictive effectiveness of ich prognosisHauke Schneider of the Department of Neurology at the University of Science and Technology in Dresden, Germany, combined with the ICH score and the CTA Speckle CHICH score, presented a new predictive model for forward-looking analysis of the value of predicting the prognosis of cerebral hemorrhage, published in the June 2018 issue of Strokethe data from 241 ICH patients in the "Using CT-Angie Spotting Signs to Predict Hematoma Enlargement and Prognosis Study in Brain Haemorrhage Patients" (PREDICT) projectThe ich patient hematoma enlargement and prognostic score method combined the ICH score with the CTA speckle cheachb ICH score, including the total score of the ICH score and the total score of the speckle value (Table 1)The three-month prognosis is grouped using the improved Rankin scale, i.e0-3 grouping and 4-6 groupingResults Multivariar analysis showed that the ICH score (OR s 3.2; 95% CI, 2.2-4.8) and the number of spots (n?1:OR?2.7; 95% CI, 1.1-7.4; n 1:OR?3.8;95% CI, 1.2-17.1) had the value of independent prediction of 3 months of prognosis, similar to that of previous studiesCompared with the single ICH score, there was no significant difference in prognostice prediction, no significant difference between the spot sign ICH scoring area under the curve and the ICH scoring area under the curve, and no significant difference (P.14)Table 1 CTA Spot Sign Score combined with ICH score scale the results of the study, based on the PREDICTION research project, combined with the CTA speckle CHIC score, the predictive value of intra-brain hematoma expansion and neurofunction prognosis was not significantly advantageous compared with a single ICH score (First Hospital of Fuzhou Serena compiled, editor-in-chief of "Outside The God Stakes" and editor-in-chief of Fudan University's affiliated Huashan Hospital
Professor Chen Chengcheng ) relevant links